Expand AMIX Menu
AMIX MENU

AMIX Latest Press Releases

-- April 3, 2025 --

Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO) Globe Newswire 8:30 AM

-- March 21, 2025 --

Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 5:00 PM

-- March 20, 2025 --

Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology Globe Newswire 8:30 AM

-- March 14, 2025 --

Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation Globe Newswire 8:30 AM

-- March 6, 2025 --

Autonomix Medical, Inc. Announces Abstract Highlighting Technology and Early Proof-of-Concept Study Results Accepted at the Society of Interventional Radiology (SIR) Annual Scientific Meeting Globe Newswire 9:00 AM

-- February 26, 2025 --

Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the LSI USA '25 Emerging Medtech Summit Globe Newswire 9:00 AM

-- February 20, 2025 --

Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting Globe Newswire 8:30 AM

-- February 19, 2025 --

Autonomix Medical, Inc. Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference Globe Newswire 9:00 AM
Virtual Investor "Top 5 for '25" Conference Hosted by JTC Now Available On-Demand ACCESS Newswire 8:56 AM

-- February 13, 2025 --

Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update Globe Newswire 8:00 AM

-- January 24, 2025 --

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Globe Newswire 8:57 AM

-- January 17, 2025 --

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025 Globe Newswire 8:00 AM

-- January 15, 2025 --

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series Globe Newswire 8:30 AM

-- January 13, 2025 --

Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting Globe Newswire 8:30 AM

-- December 30, 2024 --

Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company's Proprietary Catheter-Based Technology Globe Newswire 8:30 AM

-- December 23, 2024 --

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Globe Newswire 8:30 AM

-- December 19, 2024 --

Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and Quality Globe Newswire 8:30 AM

-- December 5, 2024 --

Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025 Globe Newswire 8:30 AM

-- November 25, 2024 --

Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option Globe Newswire 4:00 PM

-- November 22, 2024 --

Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering Globe Newswire 9:15 AM

-- November 11, 2024 --

Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update Globe Newswire 8:00 AM